Austerity cost to French industry could be well over €1bn
This article was originally published in Scrip
Executive Summary
If the French pharmaceutical industry was worried about the impact of the 2012 social security financing bill (PLFSS), its concerns will only have heightened after the deepening economic crisis in Europe led the government to announce yet more austerity measures that could see the industry more than a billion euros worse off.